You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

rAAV

Showing 51 - 75 of 79
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hemophilia A Trial in Worldwide (SPK-8011)

Recruiting
  • Hemophilia A
  • SPK-8011
  • Sacramento, California
  • +18 more
Jul 15, 2022

AADC Deficiency Trial in San Francisco, Columbus (AAV2-hAADC)

Recruiting
  • AADC Deficiency
  • San Francisco, California
  • +2 more
Jan 14, 2022

Pompe Disease Trial in Gainesville (rAAV1-CMV-GAA (study agent) Administration, RMST)

Completed
Has Results
  • Pompe Disease
  • rAAV1-CMV-GAA (study agent) Administration
  • RMST
  • Gainesville, Florida
    Shands at the University of Florida
Sep 12, 2018

Lysosomal Diseases, Gangliosidosis, GM1 Trial run by the NHGRI (biological, drug, diagnostic test, other, procedure, behavioral)

Recruiting
  • Lysosomal Diseases
  • +2 more
  • AAV9-GLB1
  • +20 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 19, 2023

Leber Congenital Amaurosis Trial in Jerusalem (rAAV2-hRPE65)

Completed
  • Leber Congenital Amaurosis
  • rAAV2-hRPE65
  • Jerusalem, Israel
    Hadassah Medical Organization
Apr 8, 2018

Leber Congenital Amaurosis Trial in Philadelphia (voretigene neparvovec-rzyl)

Completed
  • Leber Congenital Amaurosis
  • voretigene neparvovec-rzyl
  • Philadelphia, Pennsylvania
    The Children's Hospital of Philadelphia
Oct 30, 2020

HIV Trial in Guildford, Southampton (rAAV1-PG9DP)

Unknown status
  • HIV Infections
  • rAAV1-PG9DP
  • Guildford, United Kingdom
  • +1 more
Jan 9, 2018

Leber Hereditary Optic Neuropathy Trial in Wuhan (rAAV2-ND4)

Completed
Has Results
  • Leber Hereditary Optic Neuropathy
  • Wuhan, Hubei, China
    Department of Ophthalmology ，Tongji Hospital, Tongji Medical Col
Jan 7, 2018

Leber Congenital Amaurosis Trial in Worcester, Portland (rAAV2-CB-hRPE65)

Completed
Has Results
  • Leber Congenital Amaurosis
  • rAAV2-CB-hRPE65
  • Worcester, Massachusetts
  • +1 more
Dec 1, 2017

Becker Muscular Dystrophy, Sporadic Inclusion Body Myositis Trial in Columbus (rAAV1.CMV.huFollistatin344)

Completed
  • Becker Muscular Dystrophy
  • Sporadic Inclusion Body Myositis
  • rAAV1.CMV.huFollistatin344
  • Columbus, Ohio
    Nationwide Children's Hospital
Nov 21, 2017

Macular Degeneration, Age-related Maculopathies, Age-related Maculopathy Trial in Nedlands (rAAV.sFlt-1, Control (ranibizumab

Completed
  • Macular Degeneration
  • +7 more
  • rAAV.sFlt-1
  • Control (ranibizumab alone)
  • Nedlands, Western Australia, Australia
    Lions Eye Institute
Aug 30, 2017

Choroideremia Trial in United Kingdom (rAAV2.REP1)

Completed
  • Choroideremia
  • London, United Kingdom
  • +3 more
Nov 16, 2017

Alpha 1-Antitrypsin Deficiency Trial in Gainesville, Worcester (rAAV1-CB-hAAT)

Completed
Has Results
  • Alpha 1-Antitrypsin Deficiency
  • rAAV1-CB-hAAT
  • Gainesville, Florida
  • +1 more
Dec 13, 2016

Rheumatoid Arthritis Trial in Calgary (ART-I02)

Unknown status
  • Rheumatoid Arthritis
  • ART-I02
  • Calgary, Canada
    University of Calgary, Division of Rheumatology, Cumming School
Nov 13, 2018

Arthritis, Rheumatoid, Osteo Arthritis Trial in Leiden (ART-I02)

Active, not recruiting
  • Arthritis, Rheumatoid
  • Osteo Arthritis
  • ART-I02
  • Leiden, Zuid Holland, Netherlands
    Centre for Human Drug Research (CHDR)
Nov 13, 2018

Cystic Fibrosis Trial (Adeno-associated virus-CFTR vector)

Completed
  • Cystic Fibrosis
  • Adeno-associated virus-CFTR vector
  • (no location specified)
May 30, 2017

Retinal Degeneration Trial in London (tgAAG76 (rAAV 2/2.hRPE65p.hRPE65))

Completed
  • Retinal Degeneration
  • tgAAG76 (rAAV 2/2.hRPE65p.hRPE65)
  • London, United Kingdom
    Moorfields Eye Hospital NHS Foundation Trust
Dec 4, 2015

Leber Congenital Amaurosis Trial in Nantes (rAAV2/4.hRPE65)

Completed
  • Leber Congenital Amaurosis
  • Nantes, France
    CHU Nantes
Oct 6, 2015

Hepatocellular Carcinoma Trial in Guangzhou (Recombinant Human Adenovirus Type 5 Injection, Transartery Chemoembolization)

Unknown status
  • Hepatocellular Carcinoma
  • Recombinant Human Adenovirus Type 5 Injection
  • Transartery Chemoembolization
  • Guangzhou, Guangdong, China
    Cancer Center Sun Yat-sen University
Mar 14, 2017

Acute Intermittent Porphyria Trial in Pamplona, Madrid (rAAV2/5-PBGD vector dosage 1, rAAV2/5-PBGD vector dosage 2, rAAV2/5-PBGD

Completed
  • Acute Intermittent Porphyria
  • rAAV2/5-PBGD vector dosage 1
  • +3 more
  • Pamplona, Navarra, Spain
  • +1 more
Dec 17, 2014

Gastric Cancer Trial (CTL)

Active, not recruiting
  • Gastric Cancer
  • CTL
  • (no location specified)
Feb 19, 2016

Duchenne Muscular Dystrophy Trial in Columbus (rAAV2.5-CMV-minidystrophin (d3990))

Completed
  • Duchenne Muscular Dystrophy
  • rAAV2.5-CMV-minidystrophin (d3990)
  • Columbus, Ohio
    Columbus Children's Hospital
Feb 4, 2013

Muscular Dystrophies Trial in Columbus (rAAV1.tMCK.human-alpha-sarcoglycan- First cohort, Genetic:

Completed
  • Muscular Dystrophies
  • rAAV1.tMCK.human-alpha-sarcoglycan- First cohort
  • Genetic: rAAV1.tMCK.human-alpha-sarcoglycan- Second cohort
  • Columbus, Ohio
    The Research Institute at Nationwide Children's Hospital
Feb 4, 2013

Observational Study of Acute Intermittent Porphyria Patients

Completed
  • Acute Intermittent Porphyria
    • Pamplona, Navarra, Spain
    • +1 more
    Mar 11, 2014

    HIV Infection Trial in Belgium, Germany, India (tgAAC09)

    Completed
    • HIV Infection
    • tgAAC09
    • Antwerpen, Belgium
    • +4 more
    Jan 14, 2013